Clinical Trials Logo

Lung Diseases, Obstructive clinical trials

View clinical trials related to Lung Diseases, Obstructive.

Filter by:

NCT ID: NCT05654597 Recruiting - Lung Diseases Clinical Trials

French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease

Start date: April 1, 2023
Phase:
Study type: Observational

The objective of this multicentre prospective study is to validate CAPTURE as a French case finding tool for undiagnosed patients suffering from obstructive pulmonary disease.

NCT ID: NCT05652439 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

TRIBE
Start date: December 2, 2022
Phase:
Study type: Observational

The aim of this Post Authorisation Safety Study (PASS) is to assess the incidence of adverse cardiovascular and cerebrovascular events in COPD patients who are new to inhaled fixed triple therapy (dual bronchodilator plus corticosteroid) administered via Dry Powder Inhaler (DPI) compared to new users of pressurized Metered Dose Inhaler (pMDI). Data from clinical practice from different European data sources will be collected. The baseline hypothesis is that the DPI is not associated with different risks of the primary and secondary outcomes, compared with pMDI.

NCT ID: NCT05651958 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

It will be randomized controlled trial. The research will be conducted at Bahawal Victoria hospital Bahawalpur and civil hospital Bahawalpur. We take 60 patients (Epitool), Patients will be allocated randomly in two groups. Group A will get conventional medical treatment and Group B will get both conventional medical treatment and pranayama breathing exercise. Both gender of age group 30 to 55, Patient with diagnosed Chronic obstructive pulmonary disease ,Moderate to severe Chronic obstructive pulmonary disease with productive cough, Shortness of breathe and no surgical procedure performed will be included in this study. And patients of lung surgery, lung cancer, above 70 years age, with open wound, cardiovascular issues, and neurological issues will be excluded. Yoga exercise pranayama, 6 min walk test, IPAQ- quality of life and VSAQ-exercise capacity will be used as tools. Data will be analyzed on SPSS 21.

NCT ID: NCT05649423 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Postural Drainage With and Without Percussion in Chronic Obstructive Pulmonary Disease

Start date: April 10, 2022
Phase: N/A
Study type: Interventional

Effects Of postural drainage with and without percussion on mucus clearance, dyspnea and quality of life in Chronic Obstructive Pulmonary disease. 34 Patients will be explained in detail about the procedure under study. Informed consent will be taken. Subjects will be evaluated using the Modified medical research council and Dyspnea-12 Questionnaire for (dyspneal), St George's Respiratory Questionnaire for quality of life. Cough and Sputum assesment questionnaire for mucus clearance would be used. One group will be tested by Postural drainage techniques and the second group will be tested by Postural drainage with Percussion.

NCT ID: NCT05646407 Recruiting - Heart Failure Clinical Trials

Move With Air: Exercise Training Study

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the role of a stream of cool air to the face, through fan-to-face therapy, as a novel adjunct non-pharmacological therapy to enable symptomatic adults with cardiopulmonary disease to exercise at higher intensities for longer durations and maximize the psycho-physiological benefits of a supervised exercise training program. The investigators hypothesize that, compared to no fan, fan-to-face therapy will result in relatively greater improvements in exercise endurance time and intensity ratings of perceived breathlessness during constant-load cardiopulmonary exercise testing on a treadmill at 75% of peak power output following a 5-week exercise training period.

NCT ID: NCT05643729 Suspended - COPD Clinical Trials

Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)

Start date: November 15, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of Zofin for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).

NCT ID: NCT05638776 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy

Start date: June 20, 2022
Phase: Phase 2
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide with the characterization of obstructed airflow. In a large number of patients, diffusion function is impaired along with the progression of disease. REGEND001 Autologous Therapy Product, made from bronchial basal cells with ability to regenerate lung tissue, is promising to COPD treatment. In this study, a multicenter, randomized, single-blind, placebo-parallel-controlled trial is performed to assess the efficacy and safety of REGEND001 Autologous Therapy Product in treatment of chronic obstructive pulmonary disease with pulmonary diffusion dysfunction.

NCT ID: NCT05638646 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

A COPD Quality Improvement Program(QIP)

QIP
Start date: November 25, 2022
Phase: N/A
Study type: Interventional

QIP(Quality Improvement Programme) is a COPD quality improvement program in China. The initial step of this program is to set up the Quality Standards(QS) of COPD management in clinical practice, then embed Quality Standards into routine care and uses Quality Control Indicators (QCI)to check the QS implementation. The aim of the QIP program is to standardize COPD management in clinical practice in China, including the standardization of diagnosis, assessment, pharmacological and non-pharmacological intervention, and follow-up. COPD patients can benefit from standardization clinical behaviours, to be identified early, be accessed comprehensively, and be treated correctly according to guidelines, and with an appropriate follow-up to improve adherence.

NCT ID: NCT05637138 Recruiting - Clinical trials for Healthy Volunteers, Pathologies for Which paCO2 Monitoring is Crucial, Particularly in the Context of Chronic Obstructive Pulmonary Disease (COPD)

Influence of Temperature on Transcutaneous Blood Gas Diffusion: CAPNOS Project

CAPNOS
Start date: January 23, 2023
Phase: N/A
Study type: Interventional

The measurement of tcpCO2 has many disadvantages: the need for regular calibration (4 to 8 hours) of the sensor, the fact that the sensor heats the skin (risk of burns), the impossibility of measurement in ambulatory and the high cost of the monitor. In order to develop a new type of tcpCO2 sensor, it is necessary to acquire knowledge in fundamental physiology on the diffusion of CO2 through the skin.

NCT ID: NCT05632120 Enrolling by invitation - Clinical trials for Chronic Obstructive Pulmonary Disease

Investigation of Impairments in Body Functions and Structures, Activities and Participation Restrictions in COPD

Start date: December 5, 2022
Phase:
Study type: Observational

This cross-sectional study aims to investigate to the impairments in body functions and structures, activities and participation restrictions according to the International Classification of Functioning, Disability and Health (ICF) framework in Chronic Obstructive Pulmonary Diseases (COPD) patients.